Crown Bioscience
Crown Bioscience is a contract research & translational technology company making precision medicine a reality
News releases
-
Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024
Crown Bioscience is set to display significant advances in preclinical and translational oncology research at a prominent cancer research meeting, AACR 2024. The company's contributions to the cont...
-
Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row
Crown Bioscience secures the T+ Employer® certification for healthcare excellence every year since the award was inaugurated in 2020.
-
Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations
Crown Bioscience, a leading global contract research organization, successfully passed multiple ISO audits across its global facilities with no discrepancies. Its labs also renewed AAALAC accredita...
-
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Scre...
Crown Bioscience has launched OrganoidXplore, a revolutionary platform for large-scale screening of patient-derived organoids that accelerates preclinical oncology drug discovery. The platform repl...
-
Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation
Indivumed Services GmbH, a Crown Bioscience company, has received laboratory accreditation from the College of American Pathologists (CAP), highlighting its commitment to excellence in laboratory s...
-
Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
Crown Bioscience collaborates with HanX Biopharmaceutical, enabling the progression of HX009 to clinical trials for the treatment of lymphoma. The study demonstrates the efficacy of HX009 in target...